Study S001772

Comparative Effectiveness of Two Initial Combination Therapies in Patients With New Onset Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06246799
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: RECRUITING
Enrollment: 256
Start: 2024-11-07
Primary completion: 2029-04-30
Lead sponsor: The University of Texas Health Science Center at San Antonio
Conditions: Type 2 Diabetes (Adult Onset)
Interventions: DRUG:Tirzepatide; DRUG:Pioglitazone; DRUG:Sitagliptin; DRUG:Metformin HCI XR
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: NIH:R01DK097554

Registered primary outcomes

number of subjects achieving HbA1c <6.5% at 6 months (Efficacy) [6 months]
Number of subjects failing to achieving HbA1c <6.5% Long-term [month 60]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.